Patent Pick: Chanel Bets on Biology with Sestrin Activators


According to a new Chanel patent application, Sestrins (SESNs) are recently identified proteins, of which three types are found in mammals: SESN1, SESN2 and SESN3. They were first discovered as genotoxic or oxidative stress-inducible genes that, in response to stress, reduce intracellular ROS.

Log in to view the full article
More in Literature/Data